Christopher H. Yaen

Array ( [id] => 6926755 [patent_doc_number] => 20050240012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity' [patent_app_type] => utility [patent_app_number] => 11/063670 [patent_app_country] => US [patent_app_date] => 2005-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5695 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20050240012.pdf [firstpage_image] =>[orig_patent_app_number] => 11063670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5595746 [patent_doc_number] => 20060159662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Therapeutic anti-melanoma compounds' [patent_app_type] => utility [patent_app_number] => 11/031338 [patent_app_country] => US [patent_app_date] => 2005-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18877 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20060159662.pdf [firstpage_image] =>[orig_patent_app_number] => 11031338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 158761 [patent_doc_number] => 07674459 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Treatment of cancer with a novel anti-IL13 monoclonal antibody' [patent_app_type] => utility [patent_app_number] => 10/583926 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20324 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674459.pdf [firstpage_image] =>[orig_patent_app_number] => 10583926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 333991 [patent_doc_number] => 07507401 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Anti-cancer agent' [patent_app_type] => utility [patent_app_number] => 11/019360 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4166 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507401.pdf [firstpage_image] =>[orig_patent_app_number] => 11019360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085383 [patent_doc_number] => 20070275434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Apoptosis-Based Evaluation Of Chemosensitivity In Cancer Patients' [patent_app_type] => utility [patent_app_number] => 10/580170 [patent_app_country] => US [patent_app_date] => 2004-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6737 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275434.pdf [firstpage_image] =>[orig_patent_app_number] => 10580170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6990486 [patent_doc_number] => 20050089523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids' [patent_app_type] => utility [patent_app_number] => 10/988245 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 70917 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089523.pdf [firstpage_image] =>[orig_patent_app_number] => 10988245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7168404 [patent_doc_number] => 20050202019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis' [patent_app_type] => utility [patent_app_number] => 10/985324 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 30407 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202019.pdf [firstpage_image] =>[orig_patent_app_number] => 10985324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7097259 [patent_doc_number] => 20050129717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Novel uses' [patent_app_type] => utility [patent_app_number] => 10/984521 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13161 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20050129717.pdf [firstpage_image] =>[orig_patent_app_number] => 10984521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 876856 [patent_doc_number] => 07358351 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-15 [patent_title] => 'Endothelial cell expression patterns' [patent_app_type] => utility [patent_app_number] => 10/979159 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21387 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/358/07358351.pdf [firstpage_image] =>[orig_patent_app_number] => 10979159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7103427 [patent_doc_number] => 20050106153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Combined physical and immunotherapy for cancer' [patent_app_type] => utility [patent_app_number] => 10/966884 [patent_app_country] => US [patent_app_date] => 2004-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10948 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106153.pdf [firstpage_image] =>[orig_patent_app_number] => 10966884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 341743 [patent_doc_number] => 07501501 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-10 [patent_title] => 'MHC-Class II restricted melanoma antigens and their use in therapeutic methods' [patent_app_type] => utility [patent_app_number] => 10/962143 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13668 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501501.pdf [firstpage_image] =>[orig_patent_app_number] => 10962143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6939077 [patent_doc_number] => 20050112640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'PTD-modified proteins' [patent_app_type] => utility [patent_app_number] => 10/952486 [patent_app_country] => US [patent_app_date] => 2004-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11879 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112640.pdf [firstpage_image] =>[orig_patent_app_number] => 10952486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 158762 [patent_doc_number] => 07674460 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Compositions and methods for restoring sensitivity to treatment with HER2 antagonists' [patent_app_type] => utility [patent_app_number] => 10/902374 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 9943 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674460.pdf [firstpage_image] =>[orig_patent_app_number] => 10902374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 256502 [patent_doc_number] => 07576177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-18 [patent_title] => 'Hsp peptides and analogs for modulation of immune responses via antigen presenting cells' [patent_app_type] => utility [patent_app_number] => 10/902923 [patent_app_country] => US [patent_app_date] => 2004-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13117 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/576/07576177.pdf [firstpage_image] =>[orig_patent_app_number] => 10902923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7423217 [patent_doc_number] => 20040265318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Use of antibodies for the vaccination against cancer' [patent_app_type] => new [patent_app_number] => 10/901842 [patent_app_country] => US [patent_app_date] => 2004-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8614 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265318.pdf [firstpage_image] =>[orig_patent_app_number] => 10901842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 228993 [patent_doc_number] => 07601806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-13 [patent_title] => 'RTVP-GliPR-like compositions and methods for the detection, treatment and prevention of prostate cancer' [patent_app_type] => utility [patent_app_number] => 10/559994 [patent_app_country] => US [patent_app_date] => 2004-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 6 [patent_no_of_words] => 11175 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601806.pdf [firstpage_image] =>[orig_patent_app_number] => 10559994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322729 [patent_doc_number] => 07517962 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'TWEAK receptor' [patent_app_type] => utility [patent_app_number] => 10/862109 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19416 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517962.pdf [firstpage_image] =>[orig_patent_app_number] => 10862109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5040246 [patent_doc_number] => 20070092528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Superantigen fusion protein for anti-cancer therapy and methods for the production thereof' [patent_app_type] => utility [patent_app_number] => 10/571836 [patent_app_country] => US [patent_app_date] => 2004-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5571 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092528.pdf [firstpage_image] =>[orig_patent_app_number] => 10571836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 916548 [patent_doc_number] => 07323168 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-29 [patent_title] => 'Immunotherapy for chronic myelocytic leukemia' [patent_app_type] => utility [patent_app_number] => 10/853150 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9739 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/323/07323168.pdf [firstpage_image] =>[orig_patent_app_number] => 10853150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 228692 [patent_doc_number] => 07601505 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-13 [patent_title] => 'Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer' [patent_app_type] => utility [patent_app_number] => 10/855588 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44044 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/601/07601505.pdf [firstpage_image] =>[orig_patent_app_number] => 10855588 [rel_patent_id] =>[rel_patent_doc_number] =>)